Open Access
CC BY 4.0 · Arq Neuropsiquiatr 2024; 82(S 02): S53-S176
DOI: 10.1055/s-0045-1807129
ID: 753
Area: Neuromuscular diseases
Presentation method: Presentation Poster

Natural history of LAMA2 related dystrophies

Clara Gontijo Camelo
1   Universidade de São Paulo, São Paulo SP, Brazil.
,
Mariana Cunha Artilheiro
1   Universidade de São Paulo, São Paulo SP, Brazil.
,
Cristiane Araujo Martins Moreno
1   Universidade de São Paulo, São Paulo SP, Brazil.
,
Alulin Tácio Quadros Monteiro Fonseca
1   Universidade de São Paulo, São Paulo SP, Brazil.
,
Rodrigo Holanda Mendonca
1   Universidade de São Paulo, São Paulo SP, Brazil.
,
Andre Macedo Serafim da Silva
1   Universidade de São Paulo, São Paulo SP, Brazil.
,
Umbertina Conti Reed
1   Universidade de São Paulo, São Paulo SP, Brazil.
,
Edmar Zanoteli
1   Universidade de São Paulo, São Paulo SP, Brazil.
› Author Affiliations
 

    *Correspondence: claragc@gmail.com.

    Abstract

    Background: LAMA2-related dystrophies (LAMA2-RD) represent a rare neuromuscular disorder with a wide spectrum of phenotype severity, ranging from mild to severe.

    Objective: To establish disease natural history, we performed a cross-sectional study of LAMA2-RD through motor function and pulmonary tests.

    Methods: Fourty-four individuals with LAMA2-RD were included and were evaluated through functional outcome measures (MFM32, RULM, goniometry and Forced Vital Capacity (FVC)).

    Results: The most frequent phenotype presentation was non-ambulatory (N=36, 81.8%), while eight patients (18.2%) were able to walk. Non-ambulatory group presented a more severe progression of disease. Non-ambulatory patients had a 1.85% decrease in FVC/year, against 0.98%/year among ambulatory patients. In the non-ambulatory group, there was a 4.2% drop/year in MFM32-D2 domain (p<0.00001), a 2.6% drop/year in D3 domain (p<0.0001), and a 2.7% drop/year in the MFM32 global assessment (p<0.0001). However, the evaluation of upper limb function, in both groups, didn’t show statistically significant reduction. In the non-ambulatory group elbow and knee retractions worsened 3.22 degrees/year (p=0.00087) and 1.92 degrees/year, respectively. While those patients who acquired gait, elbow and knee retractions worsened 1.41 degrees/year (p=0.0003) and 1.95 degrees/year (p=0.01), respectively.

    Conclusion: This study confirmed the progressive nature of LAMA2-RD, both in ambulant and non-ambulant patients. MFM32, FVC and goniometry were identified as promising outcome measures for natural history studies and clinical trials in LAMA2-RD.


    Publication History

    Article published online:
    12 May 2025

    © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

    Thieme Revinter Publicações Ltda.
    Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil